JPMorgan Chase & Co’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104M | Sell |
2,837,228
-865,681
| -23% | -$31.8M | 0.01% | 849 |
|
|
2025
Q1 | $131M | Sell |
3,702,909
-126,440
| -3% | -$4.47M | 0.01% | 759 |
|
|
2024
Q4 | $167M | Sell |
3,829,349
-308,571
| -7% | -$13.5M | 0.01% | 673 |
|
|
2024
Q3 | $188M | Buy |
4,137,920
+1,022,345
| +33% | +$46.4M | 0.01% | 666 |
|
|
2024
Q2 | $121M | Sell |
3,115,575
-393,529
| -11% | -$15.3M | 0.01% | 774 |
|
|
2024
Q1 | $113M | Sell |
3,509,104
-882,525
| -20% | -$28.4M | 0.01% | 821 |
|
|
2023
Q4 | $126M | Buy |
4,391,629
+111,710
| +3% | +$3.2M | 0.01% | 728 |
|
|
2023
Q3 | $118M | Buy |
4,279,919
+312,166
| +8% | +$8.64M | 0.01% | 688 |
|
|
2023
Q2 | $106M | Buy |
3,967,753
+705,115
| +22% | +$18.9M | 0.01% | 754 |
|
|
2023
Q1 | $70.7M | Buy |
3,262,638
+666,584
| +26% | +$14.4M | 0.01% | 867 |
|
|
2022
Q4 | $61.8M | Buy |
2,596,054
+804,606
| +45% | +$19.2M | 0.01% | 904 |
|
|
2022
Q3 | $35.3M | Sell |
1,791,448
-61,404
| -3% | -$1.21M | 0.01% | 1098 |
|
|
2022
Q2 | $36.1M | Buy |
1,852,852
+512,237
| +38% | +$9.98M | 0.01% | 1106 |
|
|
2022
Q1 | $34.2M | Buy |
1,340,615
+58,914
| +5% | +$1.5M | ﹤0.01% | 1235 |
|
|
2021
Q4 | $32.3M | Sell |
1,281,701
-36,943
| -3% | -$930K | ﹤0.01% | 1280 |
|
|
2021
Q3 | $36.3M | Sell |
1,318,644
-66,891
| -5% | -$1.84M | ﹤0.01% | 1216 |
|
|
2021
Q2 | $44M | Buy |
1,385,535
+149,364
| +12% | +$4.74M | 0.01% | 1167 |
|
|
2021
Q1 | $56.7M | Buy |
1,236,171
+76,031
| +7% | +$3.49M | 0.01% | 1021 |
|
|
2020
Q4 | $45.9M | Buy |
1,160,140
+49,137
| +4% | +$1.95M | 0.01% | 1015 |
|
|
2020
Q3 | $37.7M | Buy |
1,111,003
+337,784
| +44% | +$11.5M | 0.01% | 1008 |
|
|
2020
Q2 | $24.4M | Buy |
773,219
+260,088
| +51% | +$8.21M | ﹤0.01% | 1136 |
|
|
2020
Q1 | $11.2M | Buy |
+513,131
| New | +$11.2M | ﹤0.01% | 1480 |
|